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Intestinal inflammation is a harmful condition in fish that can be triggered by the ingestion of soybean meal. Due to the positive
costs-benefits ratio of including soybean meal in farmed fish diets, identifying additives with intestinal anti-inflammatory effects
could contribute to solving the issues caused by this plant protein. This study evaluated the effect of incorporating lactoferrin (LF)
into a soybean meal-based diet on intestinal inflammation in zebrafish. Larvae were fed with diets containing 50% soybean meal
(50SBM) or 50SBM supplemented with LF to 0.5, 1, 1.5 g/kg (50SBM+LF0.5; 50SBM+LF1.0; 50SBM+LF1.5). The 50SBM+LF1.5
diet was the most efficient and larvae had a reduced number of neutrophils in the intestine compared with 50SBM larvae and an
indistinguishable number compared with control larvae. Likewise, the transcription of genes involved in neutrophil migration and
intestinal mucosal barrier functions (mmp9, muc2.2, and 𝛽-def-1) were increased in 50SBM larvae but were normally expressed
in 50SBM+LF1.5 larvae. To determine the influence of intestinal inflammation on the general immune response, larvae were
challenged with Edwardsiella tarda. Larvae with intestinal inflammation had increased mortality rate compared to control larvae.
Importantly, 50SBM+LF1.5 larvae had a mortality rate lower than control larvae. These results demonstrate that LF displays a dual
effect in zebrafish, acting as an intestinal anti-inflammatory agent and improving performance against bacterial infection.
1. Introduction
Intestinal inflammation in fish is a detrimental condition
that affects growth and the ability to respond to pathogens
[1]. Preventing this pathology is of particular relevance for
fish farming as small fish size and/or high fish mortality
drastically affect the competitiveness and profitability of the
aquaculture industry.
Most commercially important fish are carnivorous and
require a high-protein diet, usually provided through fish-
meal [2]. However, increased aquaculture production has
limited fishmeal availability, leading to the use of plant
proteins in fish diets [2]. Soybean meal, which is widely
available and economical, has a balanced amino acid profile,
and contains a high amount of digestible proteins, is currently
the most common plant protein source used in fish feed
[3]. Studies in different fish species, such as Atlantic salmon
(Salmo salar) [4], rainbow trout (Oncorhynchus mykiss) [5],
carp (Cyprinus carpio L.) [6], Nile tilapia (Oreochromis niloti-
cus) [7], gilthead seabream (Sparus aurata) [8], and zebrafish
(Danio rerio) [9, 10], have shown that the inclusion of soybean
meal in the diet triggers intestinal inflammation [11–14].
Nevertheless, the advantages of soybean meal outweigh its
disadvantageous effects to fish intestines.
To optimize the use of this plant protein, there is an
ongoing search to find dietary additives that could protect
the intestine from the effects of soybean meal. Traditionally,
additives have been incorporated into fish diets to control
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diseases, increase health, and improve the stress response
[1, 15–19]. However, little focus has been given to the use of
additives for controlling intestinal inflammation. At present,
there are only two studies that evaluate the effects of addi-
tives, specifically mannan-oligosaccharide and 𝛽-glucans, on
soybean meal-triggered intestinal inflammation in farmed
fish [1, 17]. These investigations indicate that only mannan-
oligosaccharide is able to decrease, to varying degrees, the
altered intestinal histology observed in fish fed with diets
including low amounts of soybean meal [1, 17].
Lactoferrin (LF) is an abundant iron-binding glyco-
protein secreted by epithelial cells and contributes to the
composition of bodily fluids in mammals, such as milk, tears,
saliva, bile, and pancreatic fluid [20, 21]. Specific LF receptors
are present on the surface of different tissues and cell types,
including the gastrointestinal tract, lungs, neutrophils, and
eosinophils [22, 23]. Previous research has demonstrated that
this glycoprotein has antimicrobial activity and can stimulate
cytokine production, enhance cell proliferation, and regulate
mucosal immunity [20, 24–26]. Due to these properties, LF
has been used in prophylactic treatments for fish against dif-
ferent infectious diseases [25, 27–29]. Furthermore, LF exerts
a potent anti-inflammatory effect in different tissues, mainly
by reducing immune cell recruitment to inflammatory sites.
During influenza virus infection, LF reduces the number
of infiltrating leukocytes in bronchoalveolar lavage fluid in
humans [30]. Likewise, LF can reduce eosinophil infiltration
to the pigs small intestine in a mechanism independent of
cytokine [31, 32]. Moreover, an in vivo study in rats and
mice demonstrated that orally administered LF prevents
intestinal injury triggered by nonsteroidal anti-inflammatory
drugs. The authors related this effect to the attenuation of
neutrophil migration to the intestine [33]. Despite these
various related studies, there are currently no reports on the
possible role of LF as an intestinal protector in fish and less so
on the possible protective effects of LF against soybean meal-
induced intestinal inflammation in fish.
Factors contributing to this lack of information are the
high costs and long-term assays involved in evaluating the
use of additives in the aquaculture industry, which is in
addition to the challenge ofworkingwithminimal precedents
on the cellular and molecular processes in many farmed
fish species. Therefore, an alternative research strategy is to
perform preliminary studies in a model fish in which many
diets can be assessed in a short period and at low costs.
Moreover, the selected fish model should facilitate under-
standing the biological processes triggered by different diets.
Considering the extensive biological literature and power-
ful biotechnological tools available for zebrafish (D. rerio),
this teleost fish is an ideal organism for immune-nutrition
research [34].
One key advantage of zebrafish is the availability of trans-
genic lines with certain fluorescently-labeled innate immune
cells, such as neutrophils [35]. Since the hallmark of inflam-
mation is neutrophil migration, these cells can be used as
inflammatory markers. This strategy has been used before
by Hedrera et al. [9], who demonstrated that soybean meal
consumption by zebrafish results in inflammatory side effects
similar to those observed in commercially farmed fish.
A primary advantage of using transgenic, fluorescently
labeled zebrafish is that the inflammatory process can be very
quickly observed, even before histological effects become
recognizable.
This study evaluated the effects of LF on intestinal inflam-
mation induced by a soybean meal-based diet in zebrafish.
By using the Tg(BACmpo:GFP)i114 transgenic zebrafish line,
neutrophil migration as part of the intestinal inflammatory
process was monitored in vivo. To complement this data, the
transcriptional levels of different markers related to mucosal
barrier functions as matrix metallopeptidase 9, mucin 2.2,
and beta-defensin 1 (mmp9, muc2.2, and 𝛽-def-1) and lipid
absorption like the fatty-acid-binding proteins 2 and 6 (fabp2
and fabp6) were evaluated. Finally, the influence of intestinal
inflammation on the immune response to Edwardsiella tarda
infection was assessed.
2. Material and Methods
2.1. Zebrafish Strains andMaintenance. Zebrafish weremain-
tained and raised at the Laboratory of Developmental Biol-
ogy, Universidad Andre´s Bello, Chile, according to stan-
dard protocols [37]. The Tg(BACmpo:GFP)i114 transgenic
zebrafish line was used [35]. All embryos were collected
through natural spawning according to Kimmel et al. [38].
Eggs were incubated in petri dishes at 28∘C for three days in
the E3 medium (5mM NaCl, 0.17mM KCl, 0.33mM CaCl
2
,
and 0.33mM MgSO
4
, with methylene blue, equilibrated to
pH 7.0) [39]. Embryonic and larval stages are expressed in
hours postfertilization (hpf) or days postfertilization (dpf).
All animal-handling procedures were approved by the Com-
mittee of Animal Bioethics of the Universidad Andre´s Bello.
2.2. Experimental Diets. Five diets were formulated and
prepared (Table 1). The positive control diet contained 50%
soybean meal (50SBM), while the negative control diet
contained fishmeal as the primary protein source (100FM)
[9]. Additionally, a diet normally used for zebrafish larvae
(ZFP, sera Micron, Heinsberg, Germany) was used as a
second negative control. To evaluate the intestinal protective
effect of LF, three batches of the 50SBM diet were supple-
mented with bovine LF obtained from milk (Lactoferrin
100% S60, Natural Healthy Concepts, Appleton, WI, USA)
in concentrations of 0.5, 1.0, or 1.5 g/kg (50SBM+LF0.5;
50SBM+LF1.0; and 50SBM+LF1.5, resp.) [40]. Likewise, one
batch of the 100FM diet was supplemented with 1.5 g/kg of
bovine LF (100FM+LF1.5). All diets were supplemented with
a standard vitamin and mineral premix and formulated to
be isoenergetic, isonitrogenous, and isolipidic. Each feed diet
was prepared by cooking-extrusion in a twin screw extruder
(CLEXTRAL BC-21, Clextral, Firminy, France) with a 2mm
diameter.The resulting moist pellets were oven-dried at 60∘C
for approximately eight hours and then coated with fish oil,
according to the formulation for each diet, using a laboratory
vacuum coater (Dinnissen Model VC10, Sevenum, Nether-
lands). The pellets were subsequently crumbled, screened to
the appropriate particle size (75𝜇m), and stored at −20∘C
until use in the feeding trials.
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Table 1: Ingredients and nutrient composition of experimental diets.
100FM 50SBM Different doses of LF incorporated into diets
50SBM+LF0.5 50SBM+LF1.0 50SBM+LF1.5 FM+LF1.5
Ingredients g/kg
Fishmeal 610 250 250 250 250 610
Soybean meal 0 500 500 500 500 0
Wheat grain meal 255 115 115 115 115 255
Starch 45 45 45 45 45 45
Fish oil 30 60 59.5 59 58.5 28.5
Vitamineral mix1 30 30 30 30 30 30
Cellulose 30 0 0 0 0 30
Lactoferrin 0 0 0.5 1 1.5 1.5
Total 1000 1000 1000 1000 1000 1000
Analytical composition (dry base, %)
Dry matter 95.3 93.5 94.0 94.0 93.04 94.27
Total proteins 46.4 43.5 43.4 43.4 43.46 44.40
Total lipids 7.8 8.4 7.6 7.6 6.78 6.39
Ash 12.6 9.7 9.8 9.8 8.25 9.76
Gross energy (MJ/kg) 20.0 20.3 20.2 20.2 20.2 20.0
1As recommended by the National Research Council, 1993 [36].
Table 2: Primer sequences used for amplification of specific genes through RT-qPCR.
Gene Forward primer Reverse primer Amplicon(bp) Gene ID Efficiency
muc2.2 ACACGCTCAAGTAATCGCACAGTC TCAGCGAGTGTTTGGCTCACTT 137 XM 002667543 1.82
mmp9 CATTAAAGATGCCCTGATGTATCCC AGTGGTGGTCCGTGGTTGAG 142 NM 213123.1 1.89
𝛽-def-1 CTCCTTGTCGTACTAGCATTGCAC ACACACTCCTTGTCTGCAAACACC 99 NM 001081553.1 1.86
fabp2 TCAACGGGACCTGGAAAGTC CCCATTTGTTCCATGAACTTCTC 61 NM 131431.1 1.86
fabp6 CTCCGCTCAATCAACACCAA TGAGATTCGGTTTCCCACTTG 59 NM 001002076.1 1.93
𝛽-actin TTCTGGTCGTACTACTGGTATTGTG ATCTTCATCAGGTAGTCTGTCAGGT 144 NM 131031.1 1.99
rpl13𝛼 TCTGGAGGACTGTAAGAGGTATGC AGACGCACAATCTTGAGAGCAG 148 NM 212784.1 1.94
Primers for mmp9, muc2.2, 𝛽-def-1, fapb2, and fabp6 were designed using AmplifX v1.4.0. Two reference genes, 𝛽-actin and ribosomal protein L13a (rpl13𝛼),
were used [10].
2.3. Experimental Feeding Period. Experimental feeding was
performed as previously described by Hedrera et al. [9].
Briefly, 45 larvae were fed two times daily from 5 to 8 dpf.The
last feed was given at least 14 h before larval fixing to promote
intestine emptying.
2.4. Immunohistochemistry and Sudan Black B Staining.
Immunohistochemistry was performed as previously
described by Feijoo et al. [41]. The following antibodies were
used: rabbit anti-Green Fluorescent Protein (anti-GFP) (Cat.
number A11122, Invitrogen, Carlsbad, CA, USA) and anti-
rabbit peroxidase (Cat. number A8275, Sigma, St. Louis, MO,
USA). Additionally, Sudan Black B staining was performed
following the manufacturer’s protocol (Cat. number 3801,
Sigma-Aldrich, St. Louis, MO, USA).The neutrophils present
in the intestine were quantified within a defined area that
included the mid and posterior intestine. At least 28 larvae
were analyzed per diet in three independent experiments.
2.5. Quantitative Polymerase Chain Reaction (qPCR). Larvae
fed with the control and experimental diets were sampled
at the end of each treatment for total RNA extraction. Total
RNA was extracted from a pool of ∼60 larval intestines per
diet. The whole intestine was dissected from larvae anes-
thetized in tricaine methanesulfonate using sterile instru-
ments. Samples were stored in the RNAlater solution and
then homogenized in the TRIzol Reagent (Cat. number
15596-026, Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. The corresponding cDNA were
synthesized from 2.5 𝜇g of total RNA using SuperScript II
Reverse Transcriptase (Cat. number 100004925, Invitrogen,
Carlsbad, CA, USA) and Oligo-dt primers. Primer sequences
and the efficiencies are shown in Table 2. qPCR was per-
formed with the ABI 7300 Real-Time PCR system using
the Maxim SYBR Green/ROX qPCR Master Mix (2x) (Fer-
mentas, Waltham, MA, USA) following the manufacturer’s
instructions. A 15 𝜇L reaction volume was used, containing
4 Journal of Immunology Research
1 𝜇L of 10-fold diluted cDNA. The PCR was run with a ten-
minute activation and denaturation step at 95∘C, followed by
40 cycles of 30 s at 95∘C, 30 s at 57–60∘C, and 30 s at 72∘C.
Reaction specificity was verified using melting curve analysis
and the absence of primer dimmers. Standard curves were
obtained for each pair of primers by plotting Ct values against
the log
10
of five different dilutions of a cDNA mix solution
for all analyzed samples. Real-time PCR efficiency (𝐸) was
calculated from a standard curve according to the equation
𝐸 = 10(−1/slope) [42]. Relative expression was calculated
with the Pfaffl method [42], and the 50SBM diet was used as
a calibrator.
2.6. cDNA Cloning, Probe Synthesis, and Whole-Mount In
Situ Hybridization. The fabp2 gene was cloned using the
following primers: F-5󸀠-CGACCGCAATGAGAACTACGA-
GAA-3󸀠 and R-5󸀠-CTCACAGGTGCAAATGACACGA-3󸀠
(gene ID: NM 131431.1) from a 9 dpf cDNA library. A 529
base pair cDNA fragment was cloned into the pGEM-T easy
vector (Promega, Madison, WI, USA), which was digested
with the ApaI restriction enzyme. The anti-sense riboprobe
was then synthesized using the Sp6 RNA polymerase. The
fabp6 clone was kindly provided by Oehlers et al. [43]. In
situ hybridization was performed as previously described by
Jowett and Lettice [44].
2.7. Edwardsiella tarda Challenge. Edwardsiella tarda FL60
was kindly provided by Dr. Phillip Klesius (USDA, Agri-
cultural Research Service, Aquatic Animal Health Research
Unit).The E. tarda culture was grown as previously described
byHarvie et al. [45] andVan Soest et al. [46], with somemod-
ifications. Briefly, E. tarda was grown overnight at 28∘C in a
trypticase soy broth medium with agitation. The overnight
culture was diluted to 1 : 100 in fresh trypticase soy broth
medium and incubated at 28∘C to reach 108 CFU/mL. The
culture was pelleted by centrifugation at 1500 g for five min-
utes, washed with water from the aquarium, and repelleted
to recover the bacteria. The clean E. tarda was suspended in
water from the aquarium to reach 108 CFU/mL. After four
days of feeding, a group of 30 larvae were challenged for 5 h
in 200mL of the E. tarda water media and were subsequently
transferred to a tank with new, clean water. Each respective
diet was resumed for the remainder of the trial period, and
larvae mortality was monitored every 12 h for four days.
2.8. Statistical Analysis and Imaging. The data were analyzed
using a nonparametric, Kruskal-Wallis, one-way ANOVA,
andDunnmultiple comparisons test.The data were normally
distributed (the D’Agostino and Pearson normality test), but
variance was not homogenous (the Brown-Forsythe test).
Survival data were analyzed using Kaplan-Meier and group
differences were analyzed by the log-rank test, using the
Bonferroni correction for multiple comparisons. All analyses
were performed using Prism 4 (GraphPad Software, La
Jolla, CA, USA). Significance was established for all analyses
at 𝑃 < 0.05. Lateral view photographs of larvae were
taken in an Olympus SZX16 stereoscope with a QImaging
MicroPublisher 5.0 RVT camera. Images were processed with
Photoshop CS4 or ImageJ v1.44.
3. Results
3.1. Effect of Soybean Meal Diet Supplemented with Lactofer-
rin on Intestinal Inflammation. To determine if LF exerted
an intestinal protector effect, by preventing or decreasing
inflammation, this additive was incorporated to the soybean
meal-based diet (50SBM), thereby generating three exper-
imental diets (50SBM+LF0.5, 50SBM+LF1.0, and 50SBM+
LF1.5). The 50SBM diet was used as a positive control that
triggers inflammation, while the 100FM and ZFP diets were
used as negative controls [9]. To determine the extent of
intestinal inflammation, the amount of neutrophils present
in the intestine was quantified (Figure 1).
Confirming previously published data, the results indi-
cated a clear increase in the number of neutrophils situated
in the intestine of larvae fed with a 50SBM diet compared
to larvae fed with the ZFP and 100FM diets (Figures 1(a)–
1(c) and 1(i)). In larvae fed with the 50SBM+LF0.5 diet, the
number of neutrophils located in the intestine showed no
significant differences compared with 50SBM larvae (Figures
1(d), 1(c), and 1(i)). On the other hand, larvae fed with the
50SBM+LF1.0 and 50SBM+LF1.5 diets presented a decreased
number of neutrophils in the intestine compared to the
50SBM group and, more importantly, these larvae were
indistinguishable from those fed the 100FM and ZFP diets
(Figures 1(e), 1(f), and 1(i)). Of significance, the amount of
intestine-located neutrophils in larvae fed the 50SBM+LF1.5
diet was similar to larvae fed the 100FM+LF1.5 diet (Figures
1(f), 1(g), and 1(i)).
To corroborate immunohistochemistry data, Sudan Black
B staining was performed to specifically label leukocytes.
Total concordance was found between the results obtained
with the two techniques (Supplementary Figure 1, in Sup-
plementary Material available online at http://dx.doi.org/
10.1155/2016/1639720).
Since LF concentrations of 1.0 and 1.5 g/kg exerted similar
effects, subsequent analyseswere performedusing the 50SBM
diet supplemented by 1.5 g/kg of LF (i.e., 50SBM+LF1.5).
3.2. Effect of SoybeanMeal Diet Supplementedwith Lactoferrin
on Genes Related to Intestinal Mucosal Function. To evaluate
the effect of LF on genes involved in intestinal mucosal
function, the transcripts of muc2.2, 𝛽-def-1, and mmp9 were
determined through qPCR. The relative expressions of these
genes in response to the different diets were compared against
expressions in larvae fed with the 50SBM diet (Figure 2,
dotted line). As expected, in larvae fed with the ZFP and
100FM control diets, the transcriptional levels of muc2.2, 𝛽-
def-1, and mmp9 were significantly lower than in larvae fed
with the 50SBM diet (𝑃 < 0.001). This same result was
observed in larvae fed the 100FM+LF1.5 diet. Notably, the
mRNA levels in larvae fed with the 50SBM+LF1.5 diet were
comparable to those observed in the ZFP and 100FM groups
and were significantly lower than those in larvae fed with the
50SBM diet (𝑃 < 0.001).
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Figure 1: Effect of different lactoferrin doses on neutrophil migration to the intestine. (a–g) Lateral view of mid and posterior intestine
of Tg(BACmpo:GFP)i114 larvae of 9 dpf after four days of feeding with different diets (ZFP, 100FM, 50SBM, 50SBM+LF0.5, 50SBM+LF1.0,
50SBM+LF1.5, and 100FM+LF1.5). Neutrophils were quantified through immunohistochemistry against GFP (white arrows). (h) Larva
scheme with the intestinal region of interest demarcated with a red rectangle. (i) The experiments were conducted with at least 28 larvae
per treatment in three different assays. Statistical analysis was performed by comparing data sets with the 50SBM diet through one-way
ANOVA.The graph is a representation of three different results. ∗∗𝑃 < 0.01; ∗∗∗∗𝑃 < 0.0001. Bar scale = 200 𝜇m.
3.3. Effect of Soybean Meal Diets Supplemented with Lacto-
ferrin on Genes Related to Intestinal Lipid Absorption. To
evaluate the effect of a 50SBM diet and LF supplementation
on the expression of genes related to the lipid absorption
process in the intestine, in situ hybridization and qPCR
were performed for the markers fabp2 and fabp6 at 9 dpf.
The fabp2 expression was restricted to the anterior intestine,
with a reduction towards the mid and posterior intestine
(Figures 3(a)–3(e), red dotted line). In contrast, fabp6 was
expressed at the mid and posterior intestine (Figures 3(g)–
3(k)). The expression of fabp6 in the defined area was similar
between larvae fed with the different diets (Figures 3(g)–
3(k), red continued line). Likewise, qPCR analysis revealed a
significant upregulation in the expression of fabp2 in control
diets (ZFP, 100FM, and 100FM+LF1.5) in comparison to those
fed with 50SBM (Figure 3(f)). The transcriptional expression
of fabp6 between control and experimental larvae did not
vary, except in larvae fed the ZFP diet, where significant
upregulation was observed (𝑃 < 0.01) (Figure 3(l)).
3.4. Effect of Intestinal Inflammation on Immune Performance
against Edwardsiella tarda. To determine if intestinal inflam-
mation affected the immune performance of the different
larvae groups, a challenge assay was performed using the
enterobacteria E. tarda (Figure 4). The challenged larvae fed
with the 50SBM diet presented significantly higher mortality
rates than those fed with the 100FM or ZFP diets (𝑃 <
0.01). However, larvae fed the 50SBM+LF1.5 diet showed
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Figure 2: Effect of lactoferrin on transcriptional levels of mucosal
barrier functional markers. Transcription levels of muc2.2, 𝛽-def-1,
andmmp9 were quantified by qPCR. Quantification was performed
from a pool of ∼60 intestines of larvae of 9 dpf after four days of
feedingwith different diets (ZFP, 100FM, 50SBM, 50SBM+LF1.5, and
100FM+LF1.5). All data were normalized with 𝛽-actin and rpl13𝛼.
The data from the different diets were compared to the 50SBM diet
(dotted lines). ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001; ∗∗∗∗𝑃 < 0.0001.
a drastic decrease in accumulated mortality at the end of
the experiment compared to 50SBM (𝑃 < 0.01), and mor-
tality rates were even lower in the 50SBM+LF1.5 group
than in larvae fed with the 100FM or ZFP diets. Similarly,
larvae fed with the 100FM+LF1.5 diet also showed reduced
accumulated mortality compared to the 100FM diet (𝑃 <
0.01). The mortality of larvae fed with the 50SBM+LF1.5
or 100FM+LF1.5 diets was comparable, and no significant
differences existed between these groups.
4. Discussion
This is the first study to provide evidence that orally admin-
istered LF protects the fish intestine from the inflammatory
effect induced by soybean meal. This observation widens the
opportunity for using this plant protein in the fish nutrition
industry.
The obtained results suggest that LF reduces neutrophil
recruitment to the intestine and that this effect is dose-
dependent. In line with this attenuated neutrophil migration,
there was a downregulation in the transcription of mmp9,
an enzyme that degrades the basement membrane to facil-
itate cell migration and infiltration to affected tissue [47].
Moreover, neutrophils are the major contributors of MMP-9
during intestinal inflammation in mammals [48, 49].
The effect of LF as an intestinal protector has been
previously reported in rodents. Dial et al. [33] found that LF
protects the intestine of rats andmice from the effects of non-
steroidal anti-inflammatory drugs. The authors speculated
that LF couldmodulate neutrophil function, attenuating neu-
trophil migration to the intestine. However, the mechanism
by which LF inhibits leukocyte migration is still unknown.
There is evidence that this protein reduces the integrin-
dependent adherence of eosinophils [50] and inhibits
the expression of adhesion molecules, such as E-selectin and
ICAM-1, in the vascular endothelium [51]. Considering that
the presence of these adhesion molecules on the surface of
the endothelium is a key step during leukocyte recruitment to
affected sites, the absence or low levels of adhesion molecules
could possibly explain the effect observed in the present
study on neutrophil migration. On the other hand, LF can
also regulate cytokine production inmice.Therefore, another
possible scenario is that, by modulating cytokine levels,
LF decreases neutrophil migration to the intestine. Data
supporting this hypothesis indicate that LF can suppress the
proinflammatory cytokines tumor necrosis factor alfa [52]
and IL-1 [53], in addition to promoting the anti-inflammatory
cytokine IL-18 in the gut [54]. Moreover, it is possible that
the decreased neutrophil migration triggered by LF is partly
a consequence of the inhibition of different proinflammatory
cytokines.
Regarding the effect of intestinal inflammation on sur-
vival rate, the challenge assay with E. tarda results clearly
indicated that an inflammatory process significantly affects
the immune response against pathogens. The present results
showed that the survival rate of larvae fed with soybean meal
was almost half of that observed in larvae fed with fishmeal
(19% and 35%, resp.). Similar results have been reported in
adult zebrafish specimens. Specifically, oxazolone-induced
intestinal inflammation resulted in treated zebrafish being
more susceptible to E. tarda infection than healthy zebrafish
[55]. Therefore, it is not the soybean meal per se that
affects the immune response against pathogens, but rather
intestinal inflammation. Moreover, in a mouse colitis model
with concomitant intestinal inflammation, infection with
Salmonella enterica was facilitated [56].
The present results further suggest that the effect of LF
on the intestine is not limited to preventing intestinal inflam-
mation but that LF can also influence larvae performance
against pathogen. This was evidenced in the challenge assay
when comparing the survival rates of larvae fed diets with or
without LF. In the case of larvae fed with fishmeal that did
not have intestinal inflammation, the survival rate increased
from 35% to 47% when LF was incorporated. Interestingly,
transcriptional analyses of muc2.2 and 𝛽-def-1 in larvae fed
with LF were indistinguishable from control larvae. These
results indicate that LF did not improve the mucosal barrier
function of the host immune response. Defensins, including
𝛽-def-1, are crucial antimicrobial peptides that protect the
intestine against infection as a result of antibacterial and
immunomodulatory properties [55, 57, 58]. Likewise, mucins
such as muc2.2 form part of the mucosal defense system
present in themucous gel layer that covers the luminal surface
of the gastrointestinal tract. This viscoelastic protective bar-
rier forms the first line of defense to the external environment
[59]. Additionally, in a chemically induced zebrafishmodel of
intestinal inflammation, the mucus layer increases [60].
Therefore, the presently observed increase in survival
rate could be the result of LF directly acting against the
invading bacteria. Indeed, LF has an antimicrobial effect
against a broad spectrum of bacteria, mainly Gram-negative
bacteria present in the gut [61]. By inhibiting the overgrowth
and/or colonization of bacterial pathogens, LF could promote
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Figure 3: Effect of lactoferrin on lipid absorption markers. (a–e) fabp2 and (g–k) fabp6 mRNA expression pattern was analyzed by whole-
mount in situ hybridization. Lateral view of larvae of 9 dpf after four days of feeding with different diets (ZFP, 100FM, 50SBM, 50SBM+LF1.5,
and 100FM+LF1.5). (a–e) fabp2 expression was restricted to anterior intestine (red dotted line). (g–k) fabp6 expression was observed in the
whole intestine, with a stronger expression in the mid and posterior gut (red continued line). (f and l) The transcriptional levels of fabp2
and fabp6 were quantified by qPCR. Data were normalized with 𝛽-actin and rpl13𝛼 and compared to 50SBM diet (dotted line). ∗𝑃 < 0.05;
∗∗
𝑃 < 0.01.
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Figure 4: Effect of lactoferrin on fish mortality after pathogen chal-
lenge. Tg(BACmpo:GFP)i114 larvae were challenged with Edward-
siella tarda after four days of feeding with different diets at 9 dpf
(ZFP, 100FM, 50SBM, 50SBM+LF1.5, and 100FM+LF1.5). Mortality
was monitored immediately after the challenge and every 12 h over
four days until 13 dpf. Statistical analysis was performed using
survival curve analysis with the log-rank test against the 100FM and
50SBM diets. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗∗𝑃 < 0.0001. Continuous
lines represent challenged larvaewhile dotted lines represent control
larvae.
a healthy condition. This inhibitory action of LF could
be achieved by the following three events: (1) chelating
ferric iron necessary for bacterial growth; (2) destabilizing
microbial membranes; or (3) modifying microbial adherence
to host cells independent of the microbe’s iron-binding
properties [62]. Obviously, the antimicrobial activities of
LF are not absolute and permit the growth of commensal
bacteria [63].
5. Conclusions
The present study provides novel and relevant data regarding
the effects of LF on fish physiology, especially in relation to
intestinal inflammation. In light of the obtained results, the
supplementation of fish diets with LF appears to be a plausible
alternative to cope, at least in part, with two major problems
currently affecting the aquaculture industry-soybean meal-
triggered enteritis and pathogenic infections.
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